Ever Supreme Bio Technology Co (ROCO:6712) Research & Development: NT$238 Mil (TTM As of Dec. 2025)


ROCO:6712 Ever Supreme Bio Technology Co Ltd ROCO:6712
88 GF Score
Price NT$158.00
GF Value NT$211.52
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ever Supreme Bio Technology Co Research & Development?

Ever Supreme Bio Technology Co ROCO:6712 +7.12% 88 Research & Development is NT$238 Mil as of Dec. 2025. GuruFocus rates ROCO:6712 with a GF Score™ of 88/100 and a GF Value™ of NT$211.52 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ever Supreme Bio Technology Co's Research & Development for the three months ended in Dec. 2025 was NT$82 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$238 Mil.

Ever Supreme Bio Technology Co  (ROCO:6712) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ever Supreme Bio Technology Co Research & Development Related Terms

Ever Supreme Bio Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Ever Supreme Bio Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ever Supreme Bio Technology Co Research & Development Chart

Ever Supreme Bio Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.14 90.69 99.11 147.22 238.16

Ever Supreme Bio Technology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.79 49.40 46.19 60.92 81.65
ROCO:6712
88GF Score
Ever Supreme Bio Technology Co Ltd ROCO:6712
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ever Supreme Bio Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$238 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$238 Mil mean?
Ever Supreme Bio Technology Co (ROCO:6712) has a Research & Development of NT$238 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Ever Supreme Bio Technology Co and its competitors.
Is Ever Supreme Bio Technology Co's Research & Development too high?
Ever Supreme Bio Technology Co's current Research & Development is NT$238 Mil. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's Research & Development compare to VRTX and REGN?
Ever Supreme Bio Technology Co's Research & Development of NT$238 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ever Supreme Bio Technology Co and its competitors. Ever Supreme Bio Technology Co's current Research & Development is NT$238 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$211.52, compared to a current price of NT$158.00 — trading 25.3% below its estimated fair value. The current Research & Development is NT$238 Mil. Ever Supreme Bio Technology Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current Research & Development is NT$238 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?

Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued. The current stock price of NT$158.00 is trading 25.3% below its estimated GF Value™ of NT$211.52. GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:6712:

  • Research & Development: NT$238 Mil
  • GF Value™: NT$211.52 vs. price of NT$158.00 (25.3% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ever Supreme Bio Technology Co Business Description

Address Keya Road, 4th Floor, No. 30, Daya District, Taichung, TWN
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
88GF Score

Get the complete analysis for ROCO:6712

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$158.00
Price
NT$211.52
GF Value